Search results
AstraZeneca Surges As It Takes A Shot At Gilead's Second-Biggest Cancer Drug
Investor's Business Daily· 9 months agoAstraZeneca and Daiichi Sankyo said Friday their breast cancer treatment outperformed chemotherapy...
AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: AstraZeneca on Tuesday reached a deal to acquire vaccine developer Icosavax in a deal...
AstraZeneca to invest $300M in US cell therapy plant
BioPharma Dive via Yahoo Finance· 4 months agoDive Brief: AstraZeneca, looking to build its presence in cell therapy, plans to invest $300 million in a new manufacturing facility in Rockville,...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 1 month agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
AstraZeneca Plummets, Sacrificing A Breakout, On Mixed Results In Lung Cancer Treatment
Investor's Business Daily· 11 months agoAstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 2 weeks agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Investor's Business Daily· 2 years agoIonis Pharmaceuticals stock tumbled Friday after partner AstraZeneca decided against sending the...
The Zacks Analyst Blog Highlights AstraZeneca, Caterpillar, Crown Castle, Nasdaq and American Water...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – October 24, 2022 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker...
Zacks via Yahoo Finance· 1 month agoFor Immediate Release Chicago, IL – May 6, 2024 – Zacks.com announces the list of stocks featured in...
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 2 weeks agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...